EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses

Kaylen Cross, Stefan W Vetter, Yousuf Alam iD, Md Zahidul Hasan iD, Anupom Deb Nath iD, Estelle Leclerc iD

Biomolecules · 04.12.2024 · 14 (12) · 1550

DOI: 10.3390/biom14121550 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.12.2024. Verfasst von Kaylen Cross und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA. Hauptthemen laut MEDLINE: Inflammation, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Dakota Department of Agriculture, NDSU Department of Pharmaceutical Sciences, NDSU College of Health and Human Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its discovery in 1992, the receptor for advanced glycation end products (RAGE) has emerged as a key receptor in many pathological conditions, especially in inflammatory conditions. RAGE is expressed by most, if not all, immune cells and can be activated by many ligands. One characteristic of RAGE is that its ligands are structurally very diverse and belong to different classes of molecules, making RAGE a promiscuous receptor. Many of RAGE ligands are damaged associated molecular patterns (DAMPs) that are released by cells under inflammatory conditions. Although RAGE has been at the center of a lot of research in the past three decades, a clear understanding of the mechanisms of RAGE activation by its ligands is still missing. In this review, we summarize the current knowledge of the role of RAGE and its ligands in inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationReceptor for Advanced Glycation End ProductsAnimalsHumansGlycation End Products, AdvancedLigandsSignal Transduction

Stichwörter der Autor:innen

DAMPRAGES100inflammationstress

Substanzen

Glycation End Products, AdvancedLigandsReceptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA.

ORCID-Profile: Yousuf Alam, Md Zahidul Hasan, Anupom Deb Nath, Estelle Leclerc

Förderung

  • North Dakota Department of Agriculture
  • NDSU Department of Pharmaceutical Sciences
  • NDSU College of Health and Human Sciences

Zitieren

APA

Cross, K., Vetter, S. W., Alam, Y., Hasan, M. Z., Nath, A. D., & Leclerc, E. (2024). Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses. Biomolecules, 14(12), 1550. https://doi.org/10.3390/biom14121550

Vancouver

Cross K, Vetter SW, Alam Y, Hasan MZ, Nath AD, Leclerc E. Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses. Biomolecules. 2024;14(12):1550. doi:10.3390/biom14121550

BibTeX
@article{Cross2024,
  author = {Cross, Kaylen and Vetter, Stefan W and Alam, Yousuf and Hasan, Md Zahidul and Nath, Anupom Deb and Leclerc, Estelle},
  title = {Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1550},
  doi = {10.3390/biom14121550}
}
Kostenlos starten →